# POTASSIUM PHOSPHATES
> **ANDA217892** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2025-01-24
## Drug
- **FDA Application Number:** ANDA217892
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** POTASSIUM PHOSPHATES
- **Generic name:** POTASSIUM PHOSPHATES
- **Active ingredients:** POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2025-01-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217892)
---
*MORVS · CC0 1.0*